ENT Oncology — MCQs

Q: Which of the following is not a cause of oropharyngeal carcinoma?

Occupational exposure to hydrochloric acid. **Explanation:** The primary risk factors for oropharyngeal carcinoma (OPC) are lifestyle-related and viral, rather than chemical or industrial. **1. Why Option A is the Correct Answer:** Occupational exposure to **hydrochloric acid (HCl)** is primarily associated with dental erosion and irritation of the upper respiratory tract, but it is **not** a recognized carcinogen for the oropharynx. In contrast, exposure to strong inorganic acid mists (like sulfuric acid) is linked specifically to **laryngeal cancer**, not oropharyngeal cancer. **2. Analysis of Other Options:** * **Smoking (Option B):** Tobacco use is a classic risk factor. Carcinogens like nitrosamines and polycyclic aromatic hydrocarbons cause field cancerization, leading to squamous cell carcinoma (SCC) of the entire aerodigestive tract. * **Human Papilloma Virus (Option C):** HPV (specifically **Type 16**) is now the leading cause of oropharyngeal cancer globally, especially involving the palatine tonsils and base of tongue. HPV-positive tumors have a better prognosis than tobacco-related ones. * **Isopropyl Oil (Option D):** Occupational exposure to the manufacture of isopropyl alcohol (specifically the "strong acid process" involving isopropyl oil) is a documented risk factor for cancers of the **paranasal sinuses and the oropharynx**. **Clinical Pearls for NEET-PG:** * **Most Common Site:** The **palatine tonsil** is the most common site for oropharyngeal SCC. * **HPV Marker:** **p16** immunohistochemistry is used as a surrogate marker for HPV-associated oropharyngeal cancer. * **Plummer-Vinson Syndrome:** Associated with post-cricoid (hypopharyngeal) carcinoma, not primarily oropharyngeal. * **Diet:** Deficiencies in Vitamin A and C are also implicated in the development of oral and pharyngeal malignancies.

Q: Epithelioid hemangioendothelioma of the nose is classified as which of the following?

Sarcoma. **Explanation:** **Epithelioid Hemangioendothelioma (EHE)** is a rare vascular neoplasm of intermediate malignancy. The correct classification is **Sarcoma** because it originates from mesenchymal tissue (specifically vascular endothelial cells). 1. **Why Sarcoma is Correct:** By definition, a sarcoma is a malignant tumor arising from mesenchymal cells (bone, cartilage, fat, muscle, or blood vessels). EHE is characterized by "epithelioid" endothelial cells that mimic epithelial cells in appearance but are positive for vascular markers like **CD31, CD34, and Factor VIII-related antigen**. It is considered an intermediate-grade vascular sarcoma, falling between a benign hemangioma and a highly aggressive angiosarcoma. 2. **Why Other Options are Incorrect:** * **Carcinoma:** These are malignant tumors of **epithelial** origin (e.g., Squamous Cell Carcinoma). While EHE has "epithelioid" features histologically, its lineage is endothelial (mesenchymal). * **Carcinosarcoma:** This is a true "mixed" tumor containing both malignant epithelial and malignant mesenchymal components. * **Hamartoma:** This is a benign, disorganized growth of mature native tissue. EHE is a neoplastic process with metastatic potential, not a developmental malformation. **High-Yield Clinical Pearls for NEET-PG:** * **Histology:** Look for "intracytoplasmic vacuoles" (lumina) containing red blood cells within epithelioid cells. * **Genetics:** Often associated with a specific translocation: **t(1;3)(p36;q25)** resulting in the **WWTR1-CAMTA1** fusion gene. * **Behavior:** It is locally invasive and has a metastatic rate of approximately 20-30%. * **Treatment:** Wide surgical excision is the primary modality; it is generally resistant to radiotherapy and chemotherapy.

Q: What is the commonest malignancy type in the oral cavity?

Squamous cell carcinoma. **Explanation:** **Correct Answer: C. Squamous cell carcinoma (SCC)** The oral cavity is lined by **stratified squamous epithelium**. Malignant transformation of these cells leads to Squamous Cell Carcinoma, which accounts for over **90-95%** of all oral cavity cancers. The primary risk factors include tobacco (smoking and smokeless), betel nut chewing, and chronic alcohol consumption. The most common site within the oral cavity for SCC is the **lower lip** (globally) or the **buccal mucosa/retro-molar trigone** (in the Indian subcontinent due to tobacco chewing habits). **Why other options are incorrect:** * **A. Adenocarcinoma:** These arise from glandular tissue. In the oral cavity, they originate from minor salivary glands. While they are the second most common group, they are far less frequent than SCC. * **B. Transitional cell carcinoma:** This type of epithelium is characteristic of the urinary tract (urothelium). It is not found in the oral cavity. * **D. Basal cell carcinoma (BCC):** BCC is a skin cancer (rodent ulcer) arising from the basal layer of the epidermis. While it commonly occurs on the face (above the line joining the tragus to the angle of the mouth), it does not arise from the oral mucosa. **High-Yield Clinical Pearls for NEET-PG:** * **Most common site (India):** Buccal mucosa (often referred to as the "Indian Oral Cancer"). * **Most common site (Global):** Lower lip. * **Premalignant conditions:** Leukoplakia (most common), Erythroplakia (highest risk of transformation), and Oral Submucous Fibrosis (OSMF). * **Lymphatic spread:** Usually to Level I, II, and III neck nodes. * **Staging:** The "Worst Pattern of Invasion" (WPOI) and "Depth of Invasion" (DOI) are critical prognostic factors in the latest AJCC staging.

Q: Recurrent or residual cancer of the nasopharynx after supervoltage radiotherapy is treated by which of the following?

All of the above. **Explanation:** The primary treatment for Nasopharyngeal Carcinoma (NPC) is **Radiotherapy (RT)** because the tumor is highly radiosensitive and the anatomical location makes primary surgical access difficult. However, managing **recurrent or residual disease** after full-course supervoltage radiotherapy is challenging because the area has already received its maximum tolerance dose of radiation. **Why "All of the above" is correct:** When external beam radiation fails, a multi-modal salvage approach is required: 1. **Intracavitary Radioactive Implants (Brachytherapy):** This allows for a high dose of radiation to be delivered directly to the tumor site while sparing the surrounding healthy tissues that were previously irradiated. Gold grains or Iridium-192 are commonly used. 2. **Surgery (Nasopharyngectomy):** While technically demanding, salvage surgery (via maxillary swing or endoscopic approaches) is indicated for localized resectable recurrences. 3. **Cryotherapy:** This is a palliative or adjunct option used to destroy localized residual tumor cells using extreme cold, especially in patients who are not candidates for major surgery. **Clinical Pearls for NEET-PG:** * **Primary Treatment of Choice:** Radiotherapy (specifically IMRT) is the gold standard for NPC. * **EBV Association:** NPC (especially Type 2 and 3) is strongly associated with the **Epstein-Barr Virus**. Monitoring EBV DNA levels is useful for detecting recurrence. * **Fossa of Rosenmüller:** This is the most common site of origin for NPC. * **Trotter’s Triad:** A classic presentation of NPC involving: 1. Conductive deafness (Eustachian tube blockage) 2. Ipsilateral temporoparietal neuralgia (CN V involvement) 3. Palatal paralysis (CN X involvement)

Q: A 13-year-old boy presents with cheek swelling and recurrent epistaxis. What is the most likely cause?

Angiofibroma. **Explanation:** The clinical presentation of a **13-year-old boy** with **recurrent epistaxis** and **cheek swelling** is a classic "spotter" for **Juvenile Nasopharyngeal Angiofibroma (JNA)**. **1. Why Angiofibroma is correct:** JNA is a benign but locally aggressive, highly vascular tumor that occurs almost exclusively in **adolescent males** (testosterone-dependent). * **Epistaxis:** The most common symptom is profuse, painless, recurrent epistaxis due to the tumor's extreme vascularity. * **Cheek Swelling:** As the tumor grows, it typically expands from the sphenopalatine foramen into the **pterygopalatine fossa** and then laterally into the **infratemporal fossa**, leading to the characteristic "frog-face" deformity or cheek swelling. **2. Why other options are incorrect:** * **Carcinoma of the nasopharynx:** While it can cause epistaxis and nasal obstruction, it is rare in young children and more commonly presents with cervical lymphadenopathy and serous otitis media. * **Rhabdomyosarcoma:** This is the most common soft tissue sarcoma in children. While it can occur in the head and neck, it usually presents as a rapidly enlarging, painful mass rather than the classic pattern of recurrent, profuse epistaxis seen in JNA. **3. High-Yield Clinical Pearls for NEET-PG:** * **Origin:** Sphenopalatine foramen (near the posterior end of the middle turbinate). * **Holman-Miller Sign (Antral Sign):** Anterior bowing of the posterior wall of the maxillary sinus seen on CT/MRI. * **Diagnosis:** Contrast-enhanced CT (CECT) is the investigation of choice. **Biopsy is strictly contraindicated** due to the risk of torrential hemorrhage. * **Treatment:** Surgical excision (Pre-operative embolization is often done to reduce blood loss).

Q: What is the standard treatment for stage T3N1 carcinoma of the maxilla?

Surgery and radiation therapy. **Explanation:** The management of maxillary sinus carcinoma depends heavily on the stage at presentation. For **Stage T3N1** (Advanced Stage), the standard of care is **multimodal therapy**, specifically **surgical resection followed by adjuvant radiotherapy**. 1. **Why Option C is correct:** Maxillary carcinomas are often diagnosed at advanced stages (T3/T4) because the sinus provides a large space for silent growth. T3 tumors involve bony structures (like the posterior wall of the maxilla, floor of the orbit, or ethmoid sinus), and N1 indicates regional lymph node involvement. Surgery (typically a Total Maxillectomy) is the primary modality to achieve local control, but due to the high risk of recurrence and nodal involvement, postoperative Radiation Therapy (RT) is mandatory to eliminate microscopic residual disease. 2. **Why other options are incorrect:** * **Option A & B:** Single-modality treatment (RT or Chemo alone) is insufficient for advanced T3/T4 lesions. RT alone has poor control rates for bone-invasive tumors. * **Option D:** While Chemoradiotherapy is used for "unresectable" cases or as an organ-preservation protocol in other head and neck cancers, surgery remains the cornerstone for maxillary sinus tumors whenever the tumor is resectable. **High-Yield Clinical Pearls for NEET-PG:** * **Most common histology:** Squamous Cell Carcinoma (SCC). * **Most common site:** The Maxillary Sinus is the most common site for paranasal sinus malignancies. * **Ohmann’s Line:** A theoretical line connecting the medial canthus to the angle of the mandible. Tumors **posterosuperior** to this line have a poorer prognosis. * **Dutton's Classification:** Often used to describe the extent of maxillary spread. * **Clinical Sign:** "Double vision" (diplopia) or cheek numbness (infraorbital nerve involvement) are classic signs of orbital floor/anterior wall involvement.

Q: Which of the following are common presentations of nasopharyngeal carcinoma?

Epistaxis and mass in the neck. **Explanation:** Nasopharyngeal Carcinoma (NPC) typically presents with a classic triad of symptoms due to its anatomical location in the Fossa of Rosenmüller. The correct answer is **Epistaxis and mass in the neck** because these represent the two most common clinical manifestations: 1. **Cervical Lymphadenopathy (Mass in the neck):** This is the most common presenting symptom (seen in ~70-80% of cases). The nodes involved are usually the upper deep cervical and the **Node of Rouviere** (lateral retropharyngeal node). 2. **Epistaxis/Nasal Symptoms:** Due to the vascular nature of the tumor and mucosal ulceration, patients often present with blood-stained nasal discharge or frank epistaxis. **Analysis of Incorrect Options:** * **Option B (Epistaxis only):** While common, it is incomplete. NPC is notorious for early lymphatic spread; therefore, a neck mass is clinically inseparable from the typical presentation. * **Option C (Epistaxis and Vertigo):** Vertigo is not a standard feature of NPC. While NPC can cause Eustachian tube blockage leading to Otitis Media with Effusion (OME) and conductive hearing loss, vestibular symptoms like vertigo are rare. **High-Yield Clinical Pearls for NEET-PG:** * **Etiology:** Strongly associated with **Epstein-Barr Virus (EBV)** and dietary factors (nitrosamines in salted fish). * **Trotter’s Triad:** A classic diagnostic triad for NPC consisting of: 1. Conductive hearing loss (due to OME). 2. Ipsilateral facial pain/Trigeminal neuralgia (CN V involvement). 3. Palatal paralysis (CN X involvement). * **Treatment of Choice:** Radiotherapy is the primary treatment (NPC is highly radiosensitive). * **Demographics:** Bimodal age distribution; highly prevalent in the Chinese population (Guangdong province).

Q: What is the most common malignant tumor of the nose?

Squamous cell carcinoma. **Explanation:** **1. Why Squamous Cell Carcinoma (SCC) is Correct:** Squamous cell carcinoma is the most common primary malignant tumor of the nasal cavity and paranasal sinuses, accounting for approximately **80% of all cases**. It typically arises from the respiratory epithelium (Schneiderian membrane) that has undergone squamous metaplasia. The most common site for SCC in the sinonasal tract is the **maxillary antrum**, followed by the nasal cavity. **2. Analysis of Incorrect Options:** * **Basal Cell Carcinoma (BCC):** While BCC is the most common malignancy of the **external skin of the nose**, it is not the most common tumor of the nasal cavity itself. NEET-PG aspirants must distinguish between "skin of the nose" (BCC) and "nasal cavity/internal nose" (SCC). * **Malignant Melanoma:** This is a rare sinonasal malignancy (approx. 1–3%). It typically arises from the nasal septum or turbinates and carries a poor prognosis due to early metastasis. * **None of the above:** Incorrect, as SCC is the established leading malignancy. **3. Clinical Pearls for NEET-PG:** * **Most common site of Sinonasal Malignancy:** Maxillary Sinus (Antrum). * **Most common benign tumor of the nose:** Inverted Papilloma (Ringertz tumor). * **Occupational Risk:** Wood dust exposure is specifically associated with **Adenocarcinoma** of the ethmoid sinuses, not SCC. * **Ohngren’s Line:** An imaginary line connecting the medial canthus to the angle of the mandible; tumors above this line (suprastructure) have a worse prognosis than those below (infrastructure). * **Clinical Presentation:** Unilateral nasal obstruction and blood-stained nasal discharge in an elderly patient should always be investigated to rule out malignancy.

Q: Keratinizing squamous cell carcinoma of the nasopharynx is classified as which type?

Type I. **Explanation:** The classification of Nasopharyngeal Carcinoma (NPC) is based on the **WHO (World Health Organization) Histopathological Classification**, which is a high-yield topic for NEET-PG. 1. **Why Type I is correct:** According to the WHO classification, **Type I** refers to **Keratinizing Squamous Cell Carcinoma**. This type is characterized by the presence of intercellular bridges and/or keratinization. Clinically, it is less common in endemic regions (like Southern China) but more common in non-endemic areas. It has the **worst prognosis** among the three types because it is less radiosensitive and has a weaker association with the Epstein-Barr Virus (EBV). 2. **Why other options are incorrect:** * **Type II:** This is **Non-keratinizing Squamous Cell Carcinoma (Differentiated)**. It shows cellular stratification but lacks overt keratinization. * **Type III:** This is **Undifferentiated Carcinoma** (also known as Lymphoepithelioma). This is the **most common type** globally, has the **best prognosis** due to high radiosensitivity, and is most strongly associated with **EBV titers**. * **Type IV:** There is no "Type IV" in the standard WHO histopathological classification for NPC. **High-Yield Clinical Pearls for NEET-PG:** * **Most common site:** Fossa of Rosenmüller. * **Etiology:** Strongly linked to EBV (Types II and III) and dietary factors (nitrosamines in salted fish). * **Clinical Triad (Trotter’s Triad):** 1. Conductive hearing loss (Eustachian tube blockage), 2. Ipsilateral facial pain (Trigeminal nerve involvement), 3. Palatal paralysis (Vagus nerve involvement). * **Treatment of Choice:** Radiotherapy (NPC is highly radiosensitive; surgery is difficult due to anatomical location).

Q: Nasal angiofibroma is commonly seen in which age group?

Adolescent male. **Explanation:** **Juvenile Nasopharyngeal Angiofibroma (JNA)** is a histologically benign but locally aggressive, highly vascular tumor. **1. Why Adolescent Male is correct:** JNA is almost exclusively seen in **adolescent males**, typically between the ages of **10 and 20 years**. The underlying medical concept is its **testosterone dependency**. The tumor is thought to arise from embryonic fibrovascular tissue in the roof of the nasopharynx (specifically the sphenopalatine foramen) and is highly sensitive to androgenic stimulation during puberty. This explains the specific age and gender predilection. **2. Why other options are incorrect:** * **Adult/Elderly Male:** While cases can occasionally be diagnosed in early adulthood, the peak incidence is during the second decade of life. In older patients, other pathologies like Nasopharyngeal Carcinoma or Inverted Papilloma are more common. * **Elderly Female:** JNA is extremely rare in females. If a similar clinical presentation occurs in a female, a genetic analysis (karyotyping) is often recommended to rule out chromosomal abnormalities, as the tumor’s growth is linked to the male hormonal profile. **3. Clinical Pearls for NEET-PG:** * **Classic Triad:** Adolescent male + Profuse recurrent epistaxis + Progressive nasal obstruction. * **Origin:** Sphenopalatine foramen (near the posterior end of the middle turbinate). * **Holman-Miller Sign (Antral Sign):** Forward bowing of the posterior wall of the maxillary sinus seen on CT/MRI. * **Diagnosis:** Clinical and radiological. **Biopsy is contraindicated** due to the risk of torrential hemorrhage. * **Treatment of Choice:** Surgical excision (Pre-operative embolization is done 24-48 hours prior to reduce blood loss).

ENT Oncology Indian Medical PG Practice Questions and MCQs

Question 1: Which of the following is not a cause of oropharyngeal carcinoma?

A. Occupational exposure to hydrochloric acid (Correct Answer)
B. Smoking
C. Human Papilloma Virus infection
D. Occupational exposure to isopropyl oil

Explanation: **Explanation:** The primary risk factors for oropharyngeal carcinoma (OPC) are lifestyle-related and viral, rather than chemical or industrial. **1. Why Option A is the Correct Answer:** Occupational exposure to **hydrochloric acid (HCl)** is primarily associated with dental erosion and irritation of the upper respiratory tract, but it is **not** a recognized carcinogen for the oropharynx. In contrast, exposure to strong inorganic acid mists (like sulfuric acid) is linked specifically to **laryngeal cancer**, not oropharyngeal cancer. **2. Analysis of Other Options:** * **Smoking (Option B):** Tobacco use is a classic risk factor. Carcinogens like nitrosamines and polycyclic aromatic hydrocarbons cause field cancerization, leading to squamous cell carcinoma (SCC) of the entire aerodigestive tract. * **Human Papilloma Virus (Option C):** HPV (specifically **Type 16**) is now the leading cause of oropharyngeal cancer globally, especially involving the palatine tonsils and base of tongue. HPV-positive tumors have a better prognosis than tobacco-related ones. * **Isopropyl Oil (Option D):** Occupational exposure to the manufacture of isopropyl alcohol (specifically the "strong acid process" involving isopropyl oil) is a documented risk factor for cancers of the **paranasal sinuses and the oropharynx**. **Clinical Pearls for NEET-PG:** * **Most Common Site:** The **palatine tonsil** is the most common site for oropharyngeal SCC. * **HPV Marker:** **p16** immunohistochemistry is used as a surrogate marker for HPV-associated oropharyngeal cancer. * **Plummer-Vinson Syndrome:** Associated with post-cricoid (hypopharyngeal) carcinoma, not primarily oropharyngeal. * **Diet:** Deficiencies in Vitamin A and C are also implicated in the development of oral and pharyngeal malignancies.

Question 2: Epithelioid hemangioendothelioma of the nose is classified as which of the following?

A. Carcinoma
B. Sarcoma (Correct Answer)
C. Carcinosarcoma
D. Hamartoma

Explanation: **Explanation:** **Epithelioid Hemangioendothelioma (EHE)** is a rare vascular neoplasm of intermediate malignancy. The correct classification is **Sarcoma** because it originates from mesenchymal tissue (specifically vascular endothelial cells). 1. **Why Sarcoma is Correct:** By definition, a sarcoma is a malignant tumor arising from mesenchymal cells (bone, cartilage, fat, muscle, or blood vessels). EHE is characterized by "epithelioid" endothelial cells that mimic epithelial cells in appearance but are positive for vascular markers like **CD31, CD34, and Factor VIII-related antigen**. It is considered an intermediate-grade vascular sarcoma, falling between a benign hemangioma and a highly aggressive angiosarcoma. 2. **Why Other Options are Incorrect:** * **Carcinoma:** These are malignant tumors of **epithelial** origin (e.g., Squamous Cell Carcinoma). While EHE has "epithelioid" features histologically, its lineage is endothelial (mesenchymal). * **Carcinosarcoma:** This is a true "mixed" tumor containing both malignant epithelial and malignant mesenchymal components. * **Hamartoma:** This is a benign, disorganized growth of mature native tissue. EHE is a neoplastic process with metastatic potential, not a developmental malformation. **High-Yield Clinical Pearls for NEET-PG:** * **Histology:** Look for "intracytoplasmic vacuoles" (lumina) containing red blood cells within epithelioid cells. * **Genetics:** Often associated with a specific translocation: **t(1;3)(p36;q25)** resulting in the **WWTR1-CAMTA1** fusion gene. * **Behavior:** It is locally invasive and has a metastatic rate of approximately 20-30%. * **Treatment:** Wide surgical excision is the primary modality; it is generally resistant to radiotherapy and chemotherapy.

Question 3: What is the commonest malignancy type in the oral cavity?

A. Adenocarcinoma
B. Transitional cell carcinoma
C. Squamous cell carcinoma (Correct Answer)
D. Basal cell carcinoma

Explanation: **Explanation:** **Correct Answer: C. Squamous cell carcinoma (SCC)** The oral cavity is lined by **stratified squamous epithelium**. Malignant transformation of these cells leads to Squamous Cell Carcinoma, which accounts for over **90-95%** of all oral cavity cancers. The primary risk factors include tobacco (smoking and smokeless), betel nut chewing, and chronic alcohol consumption. The most common site within the oral cavity for SCC is the **lower lip** (globally) or the **buccal mucosa/retro-molar trigone** (in the Indian subcontinent due to tobacco chewing habits). **Why other options are incorrect:** * **A. Adenocarcinoma:** These arise from glandular tissue. In the oral cavity, they originate from minor salivary glands. While they are the second most common group, they are far less frequent than SCC. * **B. Transitional cell carcinoma:** This type of epithelium is characteristic of the urinary tract (urothelium). It is not found in the oral cavity. * **D. Basal cell carcinoma (BCC):** BCC is a skin cancer (rodent ulcer) arising from the basal layer of the epidermis. While it commonly occurs on the face (above the line joining the tragus to the angle of the mouth), it does not arise from the oral mucosa. **High-Yield Clinical Pearls for NEET-PG:** * **Most common site (India):** Buccal mucosa (often referred to as the "Indian Oral Cancer"). * **Most common site (Global):** Lower lip. * **Premalignant conditions:** Leukoplakia (most common), Erythroplakia (highest risk of transformation), and Oral Submucous Fibrosis (OSMF). * **Lymphatic spread:** Usually to Level I, II, and III neck nodes. * **Staging:** The "Worst Pattern of Invasion" (WPOI) and "Depth of Invasion" (DOI) are critical prognostic factors in the latest AJCC staging.

Question 4: Recurrent or residual cancer of the nasopharynx after supervoltage radiotherapy is treated by which of the following?

A. Intracavitary radioactive implants
B. Cryotherapy
C. Surgery
D. All of the above (Correct Answer)

Explanation: **Explanation:** The primary treatment for Nasopharyngeal Carcinoma (NPC) is **Radiotherapy (RT)** because the tumor is highly radiosensitive and the anatomical location makes primary surgical access difficult. However, managing **recurrent or residual disease** after full-course supervoltage radiotherapy is challenging because the area has already received its maximum tolerance dose of radiation. **Why "All of the above" is correct:** When external beam radiation fails, a multi-modal salvage approach is required: 1. **Intracavitary Radioactive Implants (Brachytherapy):** This allows for a high dose of radiation to be delivered directly to the tumor site while sparing the surrounding healthy tissues that were previously irradiated. Gold grains or Iridium-192 are commonly used. 2. **Surgery (Nasopharyngectomy):** While technically demanding, salvage surgery (via maxillary swing or endoscopic approaches) is indicated for localized resectable recurrences. 3. **Cryotherapy:** This is a palliative or adjunct option used to destroy localized residual tumor cells using extreme cold, especially in patients who are not candidates for major surgery. **Clinical Pearls for NEET-PG:** * **Primary Treatment of Choice:** Radiotherapy (specifically IMRT) is the gold standard for NPC. * **EBV Association:** NPC (especially Type 2 and 3) is strongly associated with the **Epstein-Barr Virus**. Monitoring EBV DNA levels is useful for detecting recurrence. * **Fossa of Rosenmüller:** This is the most common site of origin for NPC. * **Trotter’s Triad:** A classic presentation of NPC involving: 1. Conductive deafness (Eustachian tube blockage) 2. Ipsilateral temporoparietal neuralgia (CN V involvement) 3. Palatal paralysis (CN X involvement)

Question 5: A 13-year-old boy presents with cheek swelling and recurrent epistaxis. What is the most likely cause?

A. Angiofibroma (Correct Answer)
B. Carcinoma of the nasopharynx
C. Rhabdomyosarcoma
D. None of the above

Explanation: **Explanation:** The clinical presentation of a **13-year-old boy** with **recurrent epistaxis** and **cheek swelling** is a classic "spotter" for **Juvenile Nasopharyngeal Angiofibroma (JNA)**. **1. Why Angiofibroma is correct:** JNA is a benign but locally aggressive, highly vascular tumor that occurs almost exclusively in **adolescent males** (testosterone-dependent). * **Epistaxis:** The most common symptom is profuse, painless, recurrent epistaxis due to the tumor's extreme vascularity. * **Cheek Swelling:** As the tumor grows, it typically expands from the sphenopalatine foramen into the **pterygopalatine fossa** and then laterally into the **infratemporal fossa**, leading to the characteristic "frog-face" deformity or cheek swelling. **2. Why other options are incorrect:** * **Carcinoma of the nasopharynx:** While it can cause epistaxis and nasal obstruction, it is rare in young children and more commonly presents with cervical lymphadenopathy and serous otitis media. * **Rhabdomyosarcoma:** This is the most common soft tissue sarcoma in children. While it can occur in the head and neck, it usually presents as a rapidly enlarging, painful mass rather than the classic pattern of recurrent, profuse epistaxis seen in JNA. **3. High-Yield Clinical Pearls for NEET-PG:** * **Origin:** Sphenopalatine foramen (near the posterior end of the middle turbinate). * **Holman-Miller Sign (Antral Sign):** Anterior bowing of the posterior wall of the maxillary sinus seen on CT/MRI. * **Diagnosis:** Contrast-enhanced CT (CECT) is the investigation of choice. **Biopsy is strictly contraindicated** due to the risk of torrential hemorrhage. * **Treatment:** Surgical excision (Pre-operative embolization is often done to reduce blood loss).

Question 6: What is the standard treatment for stage T3N1 carcinoma of the maxilla?

A. Radiation therapy only
B. Chemotherapy only
C. Surgery and radiation therapy (Correct Answer)
D. Chemotherapy and radiation therapy

Explanation: **Explanation:** The management of maxillary sinus carcinoma depends heavily on the stage at presentation. For **Stage T3N1** (Advanced Stage), the standard of care is **multimodal therapy**, specifically **surgical resection followed by adjuvant radiotherapy**. 1. **Why Option C is correct:** Maxillary carcinomas are often diagnosed at advanced stages (T3/T4) because the sinus provides a large space for silent growth. T3 tumors involve bony structures (like the posterior wall of the maxilla, floor of the orbit, or ethmoid sinus), and N1 indicates regional lymph node involvement. Surgery (typically a Total Maxillectomy) is the primary modality to achieve local control, but due to the high risk of recurrence and nodal involvement, postoperative Radiation Therapy (RT) is mandatory to eliminate microscopic residual disease. 2. **Why other options are incorrect:** * **Option A & B:** Single-modality treatment (RT or Chemo alone) is insufficient for advanced T3/T4 lesions. RT alone has poor control rates for bone-invasive tumors. * **Option D:** While Chemoradiotherapy is used for "unresectable" cases or as an organ-preservation protocol in other head and neck cancers, surgery remains the cornerstone for maxillary sinus tumors whenever the tumor is resectable. **High-Yield Clinical Pearls for NEET-PG:** * **Most common histology:** Squamous Cell Carcinoma (SCC). * **Most common site:** The Maxillary Sinus is the most common site for paranasal sinus malignancies. * **Ohmann’s Line:** A theoretical line connecting the medial canthus to the angle of the mandible. Tumors **posterosuperior** to this line have a poorer prognosis. * **Dutton's Classification:** Often used to describe the extent of maxillary spread. * **Clinical Sign:** "Double vision" (diplopia) or cheek numbness (infraorbital nerve involvement) are classic signs of orbital floor/anterior wall involvement.

Question 7: Which of the following are common presentations of nasopharyngeal carcinoma?

A. Epistaxis and mass in the neck
B. Epistaxis
C. Epistaxis and vertigo
D. Epistaxis and mass in the neck (Correct Answer)

Explanation: **Explanation:** Nasopharyngeal Carcinoma (NPC) typically presents with a classic triad of symptoms due to its anatomical location in the Fossa of Rosenmüller. The correct answer is **Epistaxis and mass in the neck** because these represent the two most common clinical manifestations: 1. **Cervical Lymphadenopathy (Mass in the neck):** This is the most common presenting symptom (seen in ~70-80% of cases). The nodes involved are usually the upper deep cervical and the **Node of Rouviere** (lateral retropharyngeal node). 2. **Epistaxis/Nasal Symptoms:** Due to the vascular nature of the tumor and mucosal ulceration, patients often present with blood-stained nasal discharge or frank epistaxis. **Analysis of Incorrect Options:** * **Option B (Epistaxis only):** While common, it is incomplete. NPC is notorious for early lymphatic spread; therefore, a neck mass is clinically inseparable from the typical presentation. * **Option C (Epistaxis and Vertigo):** Vertigo is not a standard feature of NPC. While NPC can cause Eustachian tube blockage leading to Otitis Media with Effusion (OME) and conductive hearing loss, vestibular symptoms like vertigo are rare. **High-Yield Clinical Pearls for NEET-PG:** * **Etiology:** Strongly associated with **Epstein-Barr Virus (EBV)** and dietary factors (nitrosamines in salted fish). * **Trotter’s Triad:** A classic diagnostic triad for NPC consisting of: 1. Conductive hearing loss (due to OME). 2. Ipsilateral facial pain/Trigeminal neuralgia (CN V involvement). 3. Palatal paralysis (CN X involvement). * **Treatment of Choice:** Radiotherapy is the primary treatment (NPC is highly radiosensitive). * **Demographics:** Bimodal age distribution; highly prevalent in the Chinese population (Guangdong province).

Question 8: What is the most common malignant tumor of the nose?

A. Squamous cell carcinoma (Correct Answer)
B. Basal cell carcinoma
C. Malignant melanoma
D. None of the above

Explanation: **Explanation:** **1. Why Squamous Cell Carcinoma (SCC) is Correct:** Squamous cell carcinoma is the most common primary malignant tumor of the nasal cavity and paranasal sinuses, accounting for approximately **80% of all cases**. It typically arises from the respiratory epithelium (Schneiderian membrane) that has undergone squamous metaplasia. The most common site for SCC in the sinonasal tract is the **maxillary antrum**, followed by the nasal cavity. **2. Analysis of Incorrect Options:** * **Basal Cell Carcinoma (BCC):** While BCC is the most common malignancy of the **external skin of the nose**, it is not the most common tumor of the nasal cavity itself. NEET-PG aspirants must distinguish between "skin of the nose" (BCC) and "nasal cavity/internal nose" (SCC). * **Malignant Melanoma:** This is a rare sinonasal malignancy (approx. 1–3%). It typically arises from the nasal septum or turbinates and carries a poor prognosis due to early metastasis. * **None of the above:** Incorrect, as SCC is the established leading malignancy. **3. Clinical Pearls for NEET-PG:** * **Most common site of Sinonasal Malignancy:** Maxillary Sinus (Antrum). * **Most common benign tumor of the nose:** Inverted Papilloma (Ringertz tumor). * **Occupational Risk:** Wood dust exposure is specifically associated with **Adenocarcinoma** of the ethmoid sinuses, not SCC. * **Ohngren’s Line:** An imaginary line connecting the medial canthus to the angle of the mandible; tumors above this line (suprastructure) have a worse prognosis than those below (infrastructure). * **Clinical Presentation:** Unilateral nasal obstruction and blood-stained nasal discharge in an elderly patient should always be investigated to rule out malignancy.

Question 9: Keratinizing squamous cell carcinoma of the nasopharynx is classified as which type?

A. Type I (Correct Answer)
B. Type II
C. Type III
D. Type IV

Explanation: **Explanation:** The classification of Nasopharyngeal Carcinoma (NPC) is based on the **WHO (World Health Organization) Histopathological Classification**, which is a high-yield topic for NEET-PG. 1. **Why Type I is correct:** According to the WHO classification, **Type I** refers to **Keratinizing Squamous Cell Carcinoma**. This type is characterized by the presence of intercellular bridges and/or keratinization. Clinically, it is less common in endemic regions (like Southern China) but more common in non-endemic areas. It has the **worst prognosis** among the three types because it is less radiosensitive and has a weaker association with the Epstein-Barr Virus (EBV). 2. **Why other options are incorrect:** * **Type II:** This is **Non-keratinizing Squamous Cell Carcinoma (Differentiated)**. It shows cellular stratification but lacks overt keratinization. * **Type III:** This is **Undifferentiated Carcinoma** (also known as Lymphoepithelioma). This is the **most common type** globally, has the **best prognosis** due to high radiosensitivity, and is most strongly associated with **EBV titers**. * **Type IV:** There is no "Type IV" in the standard WHO histopathological classification for NPC. **High-Yield Clinical Pearls for NEET-PG:** * **Most common site:** Fossa of Rosenmüller. * **Etiology:** Strongly linked to EBV (Types II and III) and dietary factors (nitrosamines in salted fish). * **Clinical Triad (Trotter’s Triad):** 1. Conductive hearing loss (Eustachian tube blockage), 2. Ipsilateral facial pain (Trigeminal nerve involvement), 3. Palatal paralysis (Vagus nerve involvement). * **Treatment of Choice:** Radiotherapy (NPC is highly radiosensitive; surgery is difficult due to anatomical location).

Question 10: Nasal angiofibroma is commonly seen in which age group?

A. Adolescent male (Correct Answer)
B. Adult male
C. Elderly male
D. Elderly female

Explanation: **Explanation:** **Juvenile Nasopharyngeal Angiofibroma (JNA)** is a histologically benign but locally aggressive, highly vascular tumor. **1. Why Adolescent Male is correct:** JNA is almost exclusively seen in **adolescent males**, typically between the ages of **10 and 20 years**. The underlying medical concept is its **testosterone dependency**. The tumor is thought to arise from embryonic fibrovascular tissue in the roof of the nasopharynx (specifically the sphenopalatine foramen) and is highly sensitive to androgenic stimulation during puberty. This explains the specific age and gender predilection. **2. Why other options are incorrect:** * **Adult/Elderly Male:** While cases can occasionally be diagnosed in early adulthood, the peak incidence is during the second decade of life. In older patients, other pathologies like Nasopharyngeal Carcinoma or Inverted Papilloma are more common. * **Elderly Female:** JNA is extremely rare in females. If a similar clinical presentation occurs in a female, a genetic analysis (karyotyping) is often recommended to rule out chromosomal abnormalities, as the tumor’s growth is linked to the male hormonal profile. **3. Clinical Pearls for NEET-PG:** * **Classic Triad:** Adolescent male + Profuse recurrent epistaxis + Progressive nasal obstruction. * **Origin:** Sphenopalatine foramen (near the posterior end of the middle turbinate). * **Holman-Miller Sign (Antral Sign):** Forward bowing of the posterior wall of the maxillary sinus seen on CT/MRI. * **Diagnosis:** Clinical and radiological. **Biopsy is contraindicated** due to the risk of torrential hemorrhage. * **Treatment of Choice:** Surgical excision (Pre-operative embolization is done 24-48 hours prior to reduce blood loss).

Practice by Chapter

Staging of Head and Neck Cancer

Practice Questions

Oral Cavity Cancer

Practice Questions

Oropharyngeal Cancer and HPV

Practice Questions

Laryngeal Cancer

Practice Questions

Hypopharyngeal Cancer

Practice Questions

Sinonasal Malignancies

Practice Questions

Salivary Gland Neoplasms

Practice Questions

Thyroid Cancer

Practice Questions

Paragangliomas

Practice Questions

Principles of Radiation Therapy

Practice Questions

Chemotherapy and Targeted Therapy

Practice Questions

Surveillance and Survivorship

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free